|
SLC35F2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.065200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.043800E-01 |
| Normal-vs-Stage2 |
4.519600E-01 |
| Normal-vs-Stage3 |
6.916200E-01 |
| Normal-vs-Stage4 |
2.060200E-02 |
| Stage1-vs-Stage2 |
7.405200E-01 |
| Stage1-vs-Stage3 |
8.468200E-01 |
| Stage1-vs-Stage4 |
4.737800E-02 |
| Stage2-vs-Stage3 |
6.455000E-01 |
| Stage2-vs-Stage4 |
2.045200E-01 |
| Stage3-vs-Stage4 |
4.619500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.161200E-01 |
| Normal-vs-AfricanAmerican |
9.250800E-01 |
| Normal-vs-Asian |
7.370200E-01 |
| Caucasian-vs-AfricanAmerican |
5.192400E-01 |
| Caucasian-vs-Asian |
8.823200E-01 |
| AfricanAmerican-vs-Asian |
7.025800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.079200E-01 |
| Normal-vs-Female |
3.619400E-01 |
| Male-vs-Female |
8.800800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.077200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.728800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.027760E-02 |
| Normal-vs-Age(81-100Yrs) |
8.858200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.326400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.006260E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.038800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.219000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.027400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.051000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.551600E-01 |
| Normal-vs-Grade 2 |
2.951600E-01 |
| Normal-vs-Grade 3 |
1.920640E-01 |
| Normal-vs-Grade 4 |
1.726780E-01 |
| Grade 1-vs-Grade 2 |
2.201000E-01 |
| Grade 1-vs-Grade 3 |
2.082200E-01 |
| Grade 1-vs-Grade 4 |
1.849830E-01 |
| Grade 2-vs-Grade 3 |
7.334200E-01 |
| Grade 2-vs-Grade 4 |
4.388800E-01 |
| Grade 3-vs-Grade 4 |
6.191400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.707440E-01 |
| Normal-vs-ccB subtype |
2.174600E-01 |
| ccA subtype-vs-ccB subtype |
8.986600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.905400E-01 |
| Normal-vs-N1 |
1.927800E-01 |
| N0-vs-N1 |
2.835000E-01 |
|
|
